5
TRANSITIONING V.A.C.
®
THERAPY INTO HOME CARE
The V.A.C.Ulta™ Therapy System is not intended for home use.
If there is a need to continue V.A.C.
®
Therapy when a patient
transitions home, consider using other KCI Therapy Systems
approved for the post-acute care environment. Refer to the
safety information included with those devices for important
information.
V.A.C.ULTA™ THERAPY SYSTEM CONTRAINDICATIONS
•
Do not place foam dressings of the V.A.C.Ulta™ Therapy System (including both V.A.C.
®
Therapy and V.A.C. VeraFlo™ Therapy Dressings) directly in contact with exposed blood
vessels, anastomotic sites, organs or nerves.
NOTE:
Refer to
Warnings
section for additional information concerning Bleeding.
•
V.A.C.
®
Therapy and V.A.C. VeraFlo™ Therapy are contraindicated for patients with:
•
Malignancy in the wound
•
Untreated osteomyelitis
NOTE:
Refer to
Warnings
section for Osteomyelitis information.
•
Non-enteric and unexplored fistulas
•
Necrotic tissue with eschar present
NOTE:
After debridement of necrotic tissue and complete removal of eschar, V.A.C.
®
Therapy may be used.
•
Sensitivity to silver (V.A.C. GranuFoam Silver
®
Dressing only)
ADDITIONAL CONTRAINDICATIONS SPECIFIC TO V.A.C. VERAFLO™
THERAPY
•
Do not use V.A.C.
®
Dressings with Octenisept
®
*, hydrogen peroxide or
solutions that are alcohol-based or contain alcohol.
•
Do not deliver fluids to the thoracic or abdominal cavity due to the potential
risk to alter core body temperature and the potential for fluid retention within
the cavity.
•
Do not use V.A.C. VeraFlo™ Therapy unless the wound has been throughly
explored due to the potential for inadvertent instillation of topical wound
solutions to adjacent body cavities.
*Not available in the United States. Brand name referenced is not a trademark of
KCI, its affiliates, or licensors.
